Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Perm J ; 21: 17-024, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28898197

RESUMO

Current treatments and the dominant model of mental health care do not adequately address the complex challenges of mental illness, which accounts for roughly one-third of adult disability globally. These circumstances call for radical change in the paradigm and practices of mental health care, including improving standards of clinician training, developing new research methods, and re-envisioning current models of mental health care delivery. Because of its dominant position in the US health care marketplace and its commitment to research and innovation, Kaiser Permanente (KP) is strategically positioned to make important contributions that will shape the future of mental health care nationally and globally.This article reviews challenges facing mental health care and proposes an agenda for developing a collaborative care model in primary care settings that incorporates conventional biomedical therapies and complementary and alternative medicine approaches. By moving beyond treatment delivery via telephone and secure video and providing earlier interventions through primary care clinics, KP is shifting the paradigm of mental health care to a collaborative care model focusing on prevention. Recommendations are to expand current practices to include integrative treatment strategies incorporating evidence-based biomedical and complementary and alternative medicine modalities that can be provided to patients using a collaborative care model. Recommendations also are made for an internal research program aimed at investigating the efficacy and cost-effectiveness of promising complementary and alternative medicine and integrative treatments addressing the complex needs of patients with severe psychiatric disorders, many of whom respond poorly to treatments available in KP mental health clinics.


Assuntos
Comportamento Cooperativo , Transtornos Mentais/terapia , Serviços de Saúde Mental/organização & administração , Atenção Primária à Saúde/organização & administração , Integração de Sistemas , Terapias Complementares/métodos , Análise Custo-Benefício , Acessibilidade aos Serviços de Saúde/organização & administração , Pesquisa sobre Serviços de Saúde , Humanos , Capacitação em Serviço , Serviços de Saúde Mental/normas , Segurança do Paciente , Guias de Prática Clínica como Assunto , Atenção Primária à Saúde/normas , Telemedicina/organização & administração
3.
JAMA Psychiatry ; 74(4): 399-405, 2017 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-28249076

RESUMO

IMPORTANCE: Several studies now provide evidence of ketamine hydrochloride's ability to produce rapid and robust antidepressant effects in patients with mood and anxiety disorders that were previously resistant to treatment. Despite the relatively small sample sizes, lack of longer-term data on efficacy, and limited data on safety provided by these studies, they have led to increased use of ketamine as an off-label treatment for mood and other psychiatric disorders. OBSERVATIONS: This review and consensus statement provides a general overview of the data on the use of ketamine for the treatment of mood disorders and highlights the limitations of the existing knowledge. While ketamine may be beneficial to some patients with mood disorders, it is important to consider the limitations of the available data and the potential risk associated with the drug when considering the treatment option. CONCLUSIONS AND RELEVANCE: The suggestions provided are intended to facilitate clinical decision making and encourage an evidence-based approach to using ketamine in the treatment of psychiatric disorders considering the limited information that is currently available. This article provides information on potentially important issues related to the off-label treatment approach that should be considered to help ensure patient safety.


Assuntos
Transtornos de Ansiedade/tratamento farmacológico , Transtorno Depressivo Resistente a Tratamento/tratamento farmacológico , Ketamina/uso terapêutico , Transtornos do Humor/tratamento farmacológico , Uso Off-Label , Transtornos de Ansiedade/diagnóstico , Transtornos de Ansiedade/psicologia , Transtorno Depressivo Resistente a Tratamento/diagnóstico , Transtorno Depressivo Resistente a Tratamento/psicologia , Relação Dose-Resposta a Droga , Medicina Baseada em Evidências , Humanos , Infusões Intravenosas , Ketamina/efeitos adversos , Transtornos do Humor/diagnóstico , Transtornos do Humor/psicologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Medição de Risco , Resultado do Tratamento
5.
Curr Cardiol Rep ; 17(11): 94, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26362300

RESUMO

Hypertension is highly prevalent affecting nearly one third of the US adult population. Though generally approached as an outpatient disorder, elevated blood pressure is observed in a majority of hospitalized patients. The spectrum of hypertensive disease ranges from patients with hypertensive emergency including markedly elevated blood pressure and associated end-organ damage to asymptomatic patients with minimally elevated pressures of unclear significance. It is important to note that current evidence-based hypertension guidelines do not specifically address inpatient hypertension. This narrative review focuses primarily on best practices for diagnosing and managing nonemergent hypertension in the inpatient setting. We describe examples of common hypertensive syndromes, provide suggestions for optimal post-acute management, and point to evidence-based or consensus guidelines where available. In addition, we describe a practical approach to managing asymptomatic elevated blood pressure observed in the inpatient setting. Finally, arranging effective care transitions to ensure optimal ongoing hypertension management is appropriate in all cases.


Assuntos
Anti-Hipertensivos/uso terapêutico , Hospitalização , Hipertensão/tratamento farmacológico , Gerenciamento Clínico , Medicina Baseada em Evidências , Insuficiência Cardíaca/complicações , Humanos , Hipertensão/etiologia , Hipertensão Renal/tratamento farmacológico , Isquemia Miocárdica/complicações
6.
J Homosex ; 58(1): 10-51, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21213174

RESUMO

Despite strong indications of elevated risk of suicidal behavior in lesbian, gay, bisexual, and transgender people, limited attention has been given to research, interventions or suicide prevention programs targeting these populations. This article is a culmination of a three-year effort by an expert panel to address the need for better understanding of suicidal behavior and suicide risk in sexual minority populations, and stimulate the development of needed prevention strategies, interventions and policy changes. This article summarizes existing research findings, and makes recommendations for addressing knowledge gaps and applying current knowledge to relevant areas of suicide prevention practice.


Assuntos
Bissexualidade/psicologia , Homossexualidade/psicologia , Prevenção do Suicídio , Transexualidade/psicologia , Feminino , Humanos , Masculino , Transtornos Mentais/psicologia , Preconceito , Pesquisa , Fatores de Risco , Ideação Suicida , Suicídio/estatística & dados numéricos , Tentativa de Suicídio/prevenção & controle , Tentativa de Suicídio/estatística & dados numéricos
7.
Perm J ; 14(3): 82, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20844714
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA